This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In an interview, Cherokee Layson-Wolf, PharmD, BCACP, FAPhA, professor of practice, sciences, and health outcomes research at the University of Maryland, explored the evolving landscape of vaccine recommendations, emphasizing the critical role pharmacists play in guiding patients through complex medical information.
In 2022, the Advisory Committee on Immunization Practices (ACIP) published updated pneumococcal vaccine recommendations. In 2022, the Advisory Committee on Immunization Practices (ACIP) published updated pneumococcal vaccine recommendations.
In an interview on vaccine recommendations, health care professionals expressed growing concerns about the changing landscape of medical information dissemination. Health care professionals emphasize patient education and reliable information in the evolving vaccine recommendation landscape.
Garofoli, PharmD, BCACP, CTTS, FAPhA Publication Article Drug Topics Journal Drug Topics May/June 2025 Volume 169 Issue 03 Pharmacy team members can help patients prepare for upcoming travels, ensuring they are up to date with the recommended vaccines for their locations. The first resource is the CDC’s Yellow Book.
Experts discuss the recent dismissal of all 17 members of the Advisory Committee on Immunization Practices (ACIP), a panel that provides guidance to the CDC on vaccine recommendations.
With significant progress made in researchers’ understanding of dermatological diseases, a pathway has been made for the development of targeted vaccines, according to data published in Vaccines. 5 Throughout the past 10 years, development of vaccines for preventing skin diseases has made significant progress.
Rite Aid, which was once the third largest pharmacy chain in the United States, announced in May that it filed its second chapter 11 bankruptcy in under 2 years. Drug Topics : How has the closure of Rite Aid stores impacted independentpharmacies in Pennsylvania? Rob Frankil, RPh : I'm seeing a mixed bag.
The FDA has approved a prefilled syringe format of the recombinant zoster vaccine Shingrix for the prevention of shingles, GSK said in a release. 1 The company said approval of the new presentation was based on data that showed comparability between the new and existing version of the vaccine.
In a vote of 5 to 1 on Thursday, members of the Advisory Committee on Immunization Practices (ACIP) voted to recommend against influenza vaccine containing the preservative thimerosal. The recommendations include all US adults as well as recommending pregnant women also receive a thimerosal-free vaccine for influenza.
I think being able to assign responsibilities that demonstrate that people have real value and real assets to their pharmacy. Even things like having a technician be in charge of inventory or immunizations or patient scheduling for our comprehensive medication reviews, giving them these roles where there are opportunities for growth.
Because technicians often understand daily pharmacy operations more intimately than pharmacists, they should be involved in decisions related to workflow, technology, and design. Many independentpharmacies already do this well, but larger chains need to catch up.
Strategies for IndependentPharmacies to Harness Consumer Trends and Meet the Competition Peter Koo, PharmD May 19th 2025 Article Pharmacies face mounting challenges amid increased competition, rising operational costs, and complex reimbursement models. 2013;3(4):e002361. 2013;3(4):e002361.
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)
This change is driven by a growing recognition that pharmacies can play a crucial role in closing patient care gaps and improving health outcomes. Payers and healthcare organizations are now willing to pay pharmacies for clinical services that go beyond traditional prescription filling.
Related Content Pharmacy Technicians Could Enhance Public Health by Becoming ‘Vaccine Champions’ Killian Meara October 3rd 2024 Article Researchers suggest that vaccine champion programs could be a promising avenue to increasing immunization rates. PMID: 40349976.
ACIP Votes to Expand RSV Vaccine Recommendation to Include Adults 50 Years and Older Ashley Gallagher April 17th 2025 Article Currently, the recommendation is for patients 75 years and older and those aged 60 to 74 years with an increased risk of severe respiratory syncytial virus.
Vaccine Coverage Remains Low Among Forcibly Displaced Children Brian Nowosielski June 17th 2025 Article Researchers conducted a systematic review and meta-analysis to estimate vaccine coverage and identify factors associated with vaccination among forcibly displaced, pediatric populations.
4 Novak added that these services align well with appointment-based models and can be layered with immunizations, chronic disease monitoring, and medication therapy management. Addressing Barriers and Finding Solutions Despite the promise of these services, challenges remain.
Kevin Cleveland, PharmD, professor at Idaho State University, explores the potential impacts of changes to the Advisory Committee on Immunization Practices (ACIP), highlighting concerns about shifting medical guidance and vaccine recommendations.
Q&A: Prioritizing Pharmacy Technician Well-Being Killian Meara ; Taylor Watterson, PharmD, PhD June 20th 2025 Article Taylor Watterson, PharmD, PhD, discusses the primary contributors to stress or frustration among pharmacy technicians and how to fix them.
Harvard Poll Shows 1 in 5 Adults Do Not Support Routine Childhood Vaccine Requirements Ashley Gallagher June 30th 2025 Article Of those who do not support vaccines, 79% said a major reason for their opposition is that it should be the parents’ choice about whether to vaccinate their child and 40% cite safety concerns.
link] Recent Videos Related Content Q&A: Expert Highlights Importance of Trusted Sources for Vaccine Information Ashley Gallagher ; Laura Knockel, PharmD, BCACP July 6th 2025 Article Health care professionals emphasize patient education and reliable information in the evolving vaccine recommendation landscape.
For example, if your goal is to grow your immunization program, don’t just say, “I want to do more vaccines.” ” Instead, set three tiers: Good: Administer 500 vaccines in 2025. Better: Hit 750 vaccines by Q4. Best: Crush it with 1,000+ vaccines and become the go-to immunization hub in town.
feedType=igFeed&tab=blocks Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Subscribe Now!
Exclusion criteria included having a bleeding disorder or having received any vaccine or monoclonal antibody for the prevention of RSV. Patients were included if they were a healthy early or moderate pre-term infant or late pre-term or full-term infant.
FDA Approves New Moderna COVID-19 Vaccine for Older Adults, High-Risk Patients Ashley Gallagher June 2nd 2025 Article The new approval is in line with recommendations that suggest booster vaccination for older adults and patients aged 12 to 64 with at least 1 or more underlying risk factors.
Key exclusion criteria included prior receipt of an HIV vaccine, prior use of long-acting systemic PrEP therapy, or prior use of HIV postexposure prophylaxis therapy. Passport to Protection: Best Practices for Travel Vaccines in the Pharmacy Setting Gretchen K.
21 / stock.adobe.com READ MORE: Progress in Dermatology Paves the Way for Vaccine Development While essential for the treatment of skin conditions like AD, each variation of TCSs is classified by its strength and risk of adverse effects. image credit: jittawit.21 J Clin Med. 2023 Oct 27;12(21):6813. doi: 10.3390/jcm12216813.
Saturday, August 2 at 2 PM Raising Your Voice in Support of Global Childhood Immunization Programs Rebecca Maxie, MPS, explores global childhood vaccination challenges and the federal appropriations process. Click here to learn more about the NPhA Annual Meeting.
1 “As a long-acting antiviral drug, CD388 was designed to provide once-per-season protection against all strains of influenza in all people, irrespective of immune status. Cidara Therapeutics Announces Positive Topline Results from its Phase 2b NAVIGATE Trial Evaluating CD388, a Non-Vaccine Preventative of Seasonal Influenza.
FDA Approves New Moderna COVID-19 Vaccine for Older Adults, High-Risk Patients Ashley Gallagher June 2nd 2025 Article The new approval is in line with recommendations that suggest booster vaccination for older adults and patients aged 12 to 64 with at least 1 or more underlying risk factors.
READ MORE: Q&A: Myths, Misinformation Surrounding Hepatitis Vaccines The study cohort included 283 patients 12 years of age or older with an acute HCV Infection who were treatment-naïve. Passport to Protection: Best Practices for Travel Vaccines in the Pharmacy Setting Gretchen K.
She hesitated, and I took her into our immunization room. She admitted she was using them for injection drug use, and I gave her 5 syringes we were using for COVID-19 vaccine injections that were provided by the government. She was most grateful and assured me she was going to seek help the next day.
Investigators found that incorporating either the pneumococcal conjugate vaccine (PCV) 20 or PCV 15 and the 23-valent pneumococcal polysaccharide vaccine (PPSV23) had an incremental budget impact of $6.5 1 The Advisory Committee on Immunization Practices voted to lower the pneumococcal recommendation to 50 years in October 2024.
In a new CDC report, investigators found that there was no connection between thimerosal in vaccines and autism or other neurodevelopmental conditions. The properties of thimerosal were documented to contribute to the safe use of multidose vials and packaging of vaccines, such as seasonal and pandemic influenza vaccines.
Become a wellness center rather than “just a pharmacy” Independentpharmacies have a significant opportunity to evolve beyond simply fulfilling prescriptions. Here’s how to turn your pharmacy into a destination for personalized care, prevention, and holistic health support.
SLE causes the immune system to make autoantibodies, proteins that attack tissues and organs in the body, including the kidneys. The symptoms can be more intense, and the disease can have long-term effects on a child's growth and quality of life,” Louise Vetter, president and CEO of Lupus Foundation of America, said in a news release.
9 In response to the fires in Los Angeles County in January 2025, a 10-year study, called the Los Angeles Fire Human Exposure and Long-Term Health Study, was launched to assess the long-term effects of wildfire smoke exposure, including respiratory, cardiovascular, neurological, reproductive, and immune system impacts.
Following a switch in Sweden’s National Immunization Program (NIP), children in the country reported an increase in pneumococcal hemolytic uremic syndrome (pHUS) from 2009 through 2024. While 90% of pediatric HUS cases are caused by Shiga toxin producing E. coli, the remaining 10% is almost entirely caused by S. pneumoniae.
Of these cases, 96% were reported in patients who were unvaccinated or had unknown vaccination status. 1 Building trust with patients through fact-based information could help boost vaccination rates to the desirable coverage. As of May 15, 2025, a total of 1024 confirmed measles cases have been reported in 31 jurisdictions.
Expanding Services Critical for Independent PharmaciesDouglas Hoey, CEO of the National Community Pharmacists Association (NCPA), discussed what pharmacies can do to increase revenue and avoid shutting their doors, as well as the importance of independentpharmacies in the health care landscape.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content